Home › Malattie autoimmuni › New York › New York City
Studi clinici su Malattie autoimmuni a New York City, NY
19 studi su Malattie autoimmuni cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
In reclutamentoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
In reclutamentoFase 3
- Memorial Sloan Kettering Cancer Center, New York
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
In reclutamentoFase 2/3
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
Daratumumab in Primary Antiphospholipid Syndrome
In reclutamentoFase 1/2
- NYU Langone, New York
- Hospital for Special Surgery, New York
- Weill Cornell, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
In reclutamentoFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
In reclutamentoFase 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
In reclutamentoFase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Abatacept for the Treatment of Giant Cell Arteritis
In reclutamentoFase 3
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
In reclutamentoFase 3
- Icahn School of Medicine at Mount Sinai, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
In reclutamentoFase 2/3
- Columbia University Irving Medical Center, New York
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
In reclutamentoFase 1/2
- Columbia University, New York
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
In reclutamentoFase 3
- Site Number - 1036, New York
- Site Number - 1034, New York
Autoimmune and Autoinflammatory Genetics Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- e altri 3
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
In reclutamentoFase 1/2
- Columbia University, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
In reclutamentoFase 1
- Montefiore Medical Center, New York
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
In reclutamentoFase 1
- Columbia University Irving Medical Center, New York
Biologics And Clinical Immunology Cohort at Sinai
In reclutamentoStudio osservazionale
- Mount Sinai, New York
Allergy and Immunology Natural History Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Studi su Malattie autoimmuni in altre città
- Houston, TX21 studi
- Washington, DC19 studi
- Philadelphia, PA16 studi
- Durham, NC15 studi
- Boston, MA13 studi
- Chicago, IL12 studi
- Los Angeles, CA12 studi
- Dallas, TX9 studi
- Atlanta, GA8 studi
- Portland, OR8 studi
- Milwaukee, WI8 studi
- Cleveland, OH8 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.